Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine

NCT01728025 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Long QT Syndrome Type 3

Interventions

DRUG: Ranolazine

Sponsor

Tel-Aviv Sourasky Medical Center